Repurposing of Chlorpromazine in Covid-19 Treatment
Status:
Not yet recruiting
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
This study evaluates the effects of the addition of chlorpromazine to the standard
therapeutic protocol in COVID-19 patients hospitalized for respiratory symptom management
(score 3-5 WHO Ordinal Scale for Clinical Improvement).